author-photo

James J. Lee

University of Pittsburgh

86

Papers

10290

Citations

Citation Trend

Filter By

Papers (58) Sort By

Journal Conference Others

Phase 1 study of safety, pharmacokinetics, and pharmacodynamics of tivantinib in combination with bevacizumab in adult patients with advanced solid tumors

2021 Cancer Chemotherapy and Pharmacology
Show All
- Source
- Cite
- Save
Citations (0)
Biomarker analysis for UPCI 14-118: Phase II study of pembrolizumab in combination with azacitidine in patients with refractory metastatic colorectal cancer.

2020 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (1)
NSABP FC-10: Phase IB study of pembrolizumab in combination with premetrexed + oaliplatin in patients (pts) with chemo-refractory metastatic colorectal cancer (mCRC).

2020 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
The effect of Sonidegib (LDE225) on the pharmacokinetics of bupropion and warfarin in patients with advanced solid tumors.

2020 British Journal of Clinical Pharmacology
Show All
- Source
- Cite
- Save
Citations (0)
Anti-PD-1 antibody cetrelimab (JNJ-63723283) in patients with advanced cancers: Updated phase I/II study results.

2019 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (4)
NSABP FC-11: A phase II study of neratinib (N) plus trastuzumab (T) or n plus cetuximab (C) in patients (pts) with "quadruple wild-type (WT)" (KRAS/NRAS/BRAF/PIK3CA WT) metastatic colorectal cancer (mCRC) based on HER2 status—Amplified (amp), non-amplified (non-amp), WT, or mutated (mt).

2019 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (1)
The association of age with acute toxicities in NRG oncology combined modality lower GI cancer trials.

2019 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
A phase 1b study evaluating the safety and pharmacokinetics of regorafenib in combination with cetuximab in patients with advanced solid tumors

2019 International Journal of Cancer
Show All
- Source
- Cite
- Save
Citations (5)
Phase II study of durvalumab following neoadjuvant chemoRT in stage II-IV rectal cancer: NSABP FR-2.

2019 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Phase Ib Results of the Rational Combination of Selumetinib and Cyclosporin A in Advanced Solid Tumors with an Expansion Cohort in Metastatic Colorectal Cancer

2018 Cancer Research
Show All
- Source
- Cite
- Save
Citations (14)